JPRN-UMIN000036655招募中未知
Efficacy and safety of Nalmefene in alcohol-dependent patients with chronic liver disease - Efficacy and safety of Nalmefene in alcohol-dependent patients
Kitasato University School of Medicine0 个研究点目标入组 100 人开始时间: 2019年5月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients with end-stage liver failure who have hepatic ascites, child-Pugh class BC and hepatic encephalopathy 2. Pregnant women or patients with potential pregnancy 3. Patients who research managers judged inappropriate as subjects
研究者
相似试验
招募中
不适用
Alcohol-related liver disease and nalmefeneJPRN-jRCT1031220022Ikejima Kenichi15
尚未招募
不适用
Effects of Nalmefene on Reduction of Drinking Alcohol and Improvement of Liver Function/Quality of Life in Patients with Alcoholic Liver Disease Treated mainly by HepatologistsAlcoholic Liver Injury, Alcohol DependenceJPRN-UMIN000048182Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine50
招募中
不适用
Effects of nalmefen on alcohol consumption in patients with alcoholic liver injury and alcohol-dependent patientsalcoholic liver injuryJPRN-UMIN000048050ara medical university Hospital Department of Gastroenterology150
尚未招募
3 期
Baclofen for Alcohol DependenceMental Health - AddictionAlcohol DependenceACTRN12606000100594Sydney South West Area Health Service42
Unknown
不适用
Nalmefene in Alcohol Dependence and Borderline Personality DisorderAlcohol Use DisorderBorderline Personality DisorderNCT02752503Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau30